Simona Guerzoni

Modena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Medication-overuse headache in migraine: could GLP-1 receptor agonists treat the addiction-like phenotype?

Medication-overuse headache in migraine: could GLP-1 receptor agonists treat the addiction-like phenotype?

Journal: Expert opinion on pharmacotherapy

Published: August 07, 2026

Innovation is not enough: lessons from lasmiditan for real-world effectiveness in acute migraine therapy.

Innovation is not enough: lessons from lasmiditan for real-world effectiveness in acute migraine therapy.

Journal: Expert review of neurotherapeutics

Published: July 08, 2026

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Journal: Cephalalgia : an international journal of headache

Published: June 26, 2026

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.

Journal: The journal of headache and pain

Published: April 21, 2026

The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Journal: Cephalalgia : an international journal of headache

Published: March 25, 2026

Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping Review.

Calcitonin Gene-Related Peptide Signalling in Alcohol Use Disorders: A Scoping Review.

Journal: Drug and alcohol review

Published: February 22, 2026

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Journal: Cephalalgia : an international journal of headache

Published: February 13, 2026

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 05, 2026

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Journal: Frontiers in neurology

Published: January 09, 2026

Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?

Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?

Journal: Expert review of neurotherapeutics

Published: November 28, 2025

Atogepant Reduces Psychological Dependence on Acute Treatments Evaluated With the Leeds Dependence Questionnaire: A Prospective Study.

Atogepant Reduces Psychological Dependence on Acute Treatments Evaluated With the Leeds Dependence Questionnaire: A Prospective Study.

Journal: Brain and behavior

Published: November 11, 2025

Title Not Found

Title Not Found

Journal: Global & regional health technology assessment

Published: September 19, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026